You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

McKinsey
Mallinckrodt
Colorcon
Boehringer Ingelheim
Moodys
Johnson and Johnson

Last Updated: August 12, 2020

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 209758

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

NDA 209758 describes POTASSIUM CITRATE, which is a drug marketed by Ut Sw Medctr, Ani Pharms Inc, Bionpharma Inc, Rising, Strides Pharma, Teva Pharms Usa Inc, and Zydus Pharms, and is included in seven NDAs. It is available from eight suppliers. Additional details are available on the POTASSIUM CITRATE profile page.

The generic ingredient in POTASSIUM CITRATE is potassium citrate. There are two hundred and forty drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the potassium citrate profile page.
Summary for 209758
Tradename:POTASSIUM CITRATE
Applicant:Teva Pharms Usa Inc
Ingredient:potassium citrate
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 209758
Medical Subject Heading (MeSH) Categories for 209758
Suppliers and Packaging for NDA: 209758
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
POTASSIUM CITRATE potassium citrate TABLET, EXTENDED RELEASE;ORAL 209758 ANDA Actavis Pharma, Inc. 0591-2682 0591-2682-01 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0591-2682-01)
POTASSIUM CITRATE potassium citrate TABLET, EXTENDED RELEASE;ORAL 209758 ANDA Actavis Pharma, Inc. 0591-2729 0591-2729-01 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0591-2729-01)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET, EXTENDED RELEASE;ORALStrength5MEQ
Approval Date:Mar 5, 2018TE:ABRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET, EXTENDED RELEASE;ORALStrength10MEQ
Approval Date:Mar 5, 2018TE:ABRLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET, EXTENDED RELEASE;ORALStrength15MEQ
Approval Date:Mar 5, 2018TE:ABRLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Merck
Boehringer Ingelheim
AstraZeneca
Dow
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.